Navidea Biopharmaceuticals Gross Profit 2010-2023 | NAVB
Navidea Biopharmaceuticals gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Navidea Biopharmaceuticals Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2022 | $-0 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $1 |
| 2018 | $1 |
| 2017 | $2 |
| 2016 | $5 |
| 2015 | $3 |
| 2014 | $5 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $1 |
| 2010 | $1 |
| 2009 | $ |
| Navidea Biopharmaceuticals Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | $-0 |
| 2022-09-30 | $-0 |
| 2022-06-30 | $0 |
| 2022-03-31 | |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $1 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $1 |
| 2016-09-30 | $2 |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | $-5 |
| 2015-09-30 | $4 |
| 2015-06-30 | $3 |
| 2015-03-31 | $2 |
| 2014-12-31 | $2 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | |
| 2012-12-31 | $0 |
| 2012-09-30 | |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $2 |
| 2010-03-31 | $2 |
| 2009-12-31 | |
| 2009-09-30 | $2 |
| 2009-06-30 | $1 |
| 2009-03-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.004B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $208.893B | 25.41 |
| Intuitive Surgical (ISRG) | United States | $132.624B | 82.78 |
| Edwards Lifesciences (EW) | United States | $52.512B | 34.76 |
| DexCom (DXCM) | United States | $51.605B | 88.65 |
| IQVIA Holdings (IQV) | United States | $41.246B | 24.46 |
| IDEXX Laboratories (IDXX) | United States | $39.720B | 47.49 |
| Alcon (ALC) | Switzerland | $38.955B | 28.73 |
| STERIS (STE) | Ireland | $19.787B | 23.42 |
| Waters (WAT) | United States | $18.041B | 25.89 |
| Hologic (HOLX) | United States | $17.586B | 19.41 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.281B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.132B | 13.75 |
| Sysmex ADR (SSMXY) | Japan | $9.874B | 30.97 |
| Teleflex (TFX) | United States | $9.811B | 15.41 |
| Penumbra (PEN) | United States | $8.077B | 99.85 |
| Masimo (MASI) | United States | $7.229B | 40.54 |
| Globus Medical (GMED) | United States | $6.931B | 21.97 |
| Glaukos (GKOS) | United States | $4.863B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.971B | 25.38 |
| TransMedics (TMDX) | United States | $2.874B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.799B | 18.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.639B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.635B | 18.08 |
| Integra LifeSciences Holdings (IART) | United States | $2.511B | 10.30 |
| Nihon Kohden (NHNKY) | Japan | $2.303B | 19.48 |
| Inari Medical (NARI) | United States | $2.243B | 387.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.050B | 0.00 |
| RxSight (RXST) | United States | $1.954B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.726B | 0.00 |
| Veracyte (VCYT) | United States | $1.416B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.99 |
| Artivion (AORT) | United States | $0.822B | 94.95 |
| Paragon 28 (FNA) | United States | $0.807B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.711B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.704B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.684B | 0.00 |
| SiBone (SIBN) | United States | $0.625B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 18.52 |
| IRadimed (IRMD) | United States | $0.513B | 29.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Nevro (NVRO) | United States | $0.451B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.413B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
| NeuroPace (NPCE) | United States | $0.361B | 0.00 |
| CVRx (CVRX) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 11.33 |
| AxoGen (AXGN) | United States | $0.303B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.273B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.267B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.254B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.180B | 9.72 |
| Atossa Genetics (ATOS) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.150B | 0.00 |
| Neuronetics (STIM) | United States | $0.119B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.114B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.108B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Vasomedical (VASO) | United States | $0.055B | 9.83 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 108.33 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.036B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |